Newsletter 4 th Edition October 2011 Predicting 5
Newsletter 4 th Edition October 2011. Predicting 5 -Aminosalicylate Nephrotoxicity in patients with IBD -an international IBD Genetics Consortium Project Thank you to the sites who have recently recruited: Prof Hawkley, Nottingham; Dr Mansfield, Newcastle; Dr Cooney, Birmingham; Dr Tremelling, Norwich; Dr Direkze, Frimley Park; Dr Muller, Kent; Dr Simmons, Reading; Dr Quinlan, Bath; Dr Harbord, Chelsea; Dr Gore, Yeovil; Dr Chaudhary, West Herts; Dr Dunckley, Gloucestershire; Dr Smith, Shrewsbury; Dr Soloman, Lancashire; Dr Hart, St Mary’s. Highest recruiter so far – Dr Parkes, Cambridge with 4 patient!! Quickest time to recruit 1 st Patient from site opening is Dr Vani, Mid Yorks If you are having difficulties locating baseline results please call the team to discuss. 01392 406928. UK sites opened in blue and patients recruited in red PRED 4 will open in November looking at 4 different drug side effects. Thiopurine induced pancreatitis Thiopurine induced myelosuppression Anti-TNF induced demyelination PPI induced interstitial nephritis. For further information please contact Claire If any identified precious patients are reluctant to participate due to pending litigation please contact Claire. There are 98 sites open to recruitment. We would like it if all sites (who have not already done so) could have their 1 st patient recruited by the beginning of December 2011. Dr Tariq Ahmad (CI). Email: Tariq. ahmad@rdeft. nhs. uk. Newsletter 3 rd Claire Bewshea Project Manager 01392 406928; Mobile: 07900 161244 or Claire. Bewshea@rdeft. nhs. uk. : Tracey Hill Study Coordinator; . 01392 406914; Tracey. Hill@rdeft. nhs. uk. Edition August Dr Kenji So, Research Fellow and Co-investigator: Tel: 01392 402840; Mobile: 07760449147 2011 Please remember to fax in your recruitment logs
- Slides: 1